Impressive response to four cemiplimab cycles of a sonidegib-resistant giant basosquamous carcinoma of the midface.

Authors	T Gambichler, I Stricker, M Neid, A Tannapfel, L Susok
Journal	Journal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 36 Issue 6 Pg. e490-e492 (06 2022) ISSN: 1468-3083 [Electronic] England
PMID	35143084 (Publication Type: Letter)
Chemical References	Antibodies, Monoclonal, Humanized Biphenyl Compounds Pyridines sonidegib cemiplimab
Topics	Antibodies, Monoclonal, Humanized (therapeutic use) Biphenyl Compounds Carcinoma, Basosquamous Humans Pyridines Skin Neoplasms (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!